ImmunOs Therapeutics

Biotechnology Research • Schlieren, Zurich, Switzerland • 11-20 Employees

Company overview

Headquarters	Wagistrasse 18, Schlieren, Zurich 8952, CH
Website	immunostherapeutics.com
SIC	873
Keywords	Global, Biotech, Leadership, Sales And Marketing, Research And Development, Pharmaceuticals, Clinical Research, Business Development, Oncology, Immunology, Immuno-Oncology
Founded	2014
Employees	11-20
Socials

Key Contact at ImmunOs Therapeutics

Reinhard Ambros

Chairman Of The Board Of Directors

ImmunOs Therapeutics Email Formats

ImmunOs Therapeutics uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@immunostherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@immunostherapeutics.com	100%

About ImmunOs Therapeutics

ImmunOs Therapeutics AG is developing the next generation of immunotherapies that have a role in the innate immune system for cancer and autoimmune diseases. The company is developing therapies that not only have direct anti-tumor effects but also remodel the tumor microenvironment to enhance the efficacy of existing immunotherapies. This portfolio of next generation, novel immunomodulatory proteins target diverse and key immunoregulatory receptors. Our lead program iosH2, now advancing to Phase 1 studies, is a multi-functional fusion protein that blocks specific LILRB (leukocyte immunoglobulin-like) receptors and thereby activates anti-tumor responses in multiple cancers with monotherapy and in combination with checkpoint inhibitors (CTLA-4, PD-1, PD-L1, CD47) and costimulatory agonists (e.g. 4-1BB).

ImmunOs Therapeutics revenue & valuation

Annual revenue	$4,000,000
Revenue per employee	$308,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$12,800,000
Total funding	$83,900,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Manager

Partner

Employees by Department

ImmunOs Therapeutics has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore ImmunOs Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-07-07	5	$72,900,000
2024-10-17	6	$11,000,000

Funding Insights

$83,900,000

Total funding amount

$11,000,000

Most recent funding amount

Number of funding rounds

ImmunOs Therapeutics Tech Stack

Discover the technologies and tools that power ImmunOs Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Contact Form 7

Form builders

PHP

Programming languages

Open Graph

Miscellaneous

WordPress

Blogs

PWA

Miscellaneous

Matomo Analytics

Analytics

MySQL

Databases

Priority Hints

Performance

Microsoft 365

Yoast SEO

SEO

Frequently asked questions

ImmunOs Therapeutics is located in Schlieren, Zurich, CH.

ImmunOs Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

ImmunOs Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

ImmunOs Therapeutics has raised a total of $83,900,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at ImmunOs Therapeutics

Reinhard Ambros

Chairman Of The Board Of Directors

4.8

40,000 users